Sygnature Discovery, an integrated drug discovery provider, is joining forces with Axol Bioscience, a company involved in scientific collaboration with human induced pluripotent stem cell (iPSC), to explore the incorporation of human iPSC-derived microglia into high-content imaging in vitroscreening workflows. Human iPSC-derived cells are stem cells derived from patient donors that are a powerful tool in biomedical research due to their ability to differentiate into various cell types found i...